Patents by Inventor Matthew William Carson

Matthew William Carson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (E)-N-{3-[1-(8-fluoro-11H-10-OXA-1-AZA-dibenzo [A,D] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis
    Patent number: 8101761
    Abstract: The present invention provides Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and discloses methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 8, 2009
    Date of Patent: January 24, 2012
    Assignee: Eli Lilly and Company
    Inventors: Matthew William Carson, Michael Joseph Coghlan
  • Glucocorticoid receptor modulator and methods of use
    Patent number: 8101760
    Abstract: The present invention provides Compound (I): Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: January 24, 2012
    Assignee: Eli Lilly and Company
    Inventors: Matthew William Carson, Michael Joseph Coghlan
  • (E)-N--METHANESULFONAMIDE AS GLUCOCORTICOID RECEPTOR MODULATOR FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Publication number: 20100280062
    Abstract: The present invention provides Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and discloses methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 8, 2009
    Publication date: November 4, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Matthew William Carson, Michael Joseph Coghlan
  • GLUCOCORTICOID RECEPTOR MODULATOR AND METHODS OF USE
    Publication number: 20100069425
    Abstract: The present invention provides Compound (I): Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 12, 2007
    Publication date: March 18, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Matthew William Carson, Michael Joseph Coghlan